{"id":"https://openalex.org/W3171409443","doi":"https://doi.org/10.1093/jac/dkab189","title":"Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?","display_name":"Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?","publication_year":2021,"publication_date":"2021-05-13","ids":{"openalex":"https://openalex.org/W3171409443","doi":"https://doi.org/10.1093/jac/dkab189","mag":"3171409443","pmid":"https://pubmed.ncbi.nlm.nih.gov/34142123","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8361339"},"language":"en","primary_location":{"id":"doi:10.1093/jac/dkab189","doi":"https://doi.org/10.1093/jac/dkab189","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dkab189","pdf_url":"https://academic.oup.com/jac/article-pdf/76/9/2230/39711670/dkab189.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/jac/article-pdf/76/9/2230/39711670/dkab189.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021680442","display_name":"Julian A. Hiscox","orcid":"https://orcid.org/0000-0002-6582-0275","observed_orcids":["https://orcid.org/0000-0002-6582-0275","https://orcid.org/0000-0001-6356-6595"]},"institutions":[{"id":"https://openalex.org/I115228651","display_name":"Agency for Science, Technology and Research","ror":"https://ror.org/036wvzt09","country_code":"SG","type":"government","lineage":["https://openalex.org/I115228651"]},{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB","SG"],"is_corresponding":false,"raw_author_name":"Julian A. Hiscox","raw_affiliation_strings":["Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK","Infectious Diseases Horizontal Technology Centre (ID HTC), A*STAR, Singapore"],"raw_orcid":"https://orcid.org/0000-0002-6582-0275","affiliations":[{"raw_affiliation_string":"Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]},{"raw_affiliation_string":"Infectious Diseases Horizontal Technology Centre (ID HTC), A*STAR, Singapore","institution_ids":["https://openalex.org/I115228651"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041365930","display_name":"Saye Khoo","orcid":"https://orcid.org/0000-0002-2769-0967","observed_orcids":["https://orcid.org/0000-0002-2769-0967"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Saye H. Khoo","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK"],"raw_orcid":"https://orcid.org/0000-0002-2769-0967","affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034472956","display_name":"James P. Stewart","orcid":"https://orcid.org/0000-0002-8928-2037","observed_orcids":["https://orcid.org/0000-0002-8928-2037","https://orcid.org/0000-0002-2902-4968"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James P. Stewart","raw_affiliation_strings":["Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK"],"raw_orcid":"https://orcid.org/0000-0002-8928-2037","affiliations":[{"raw_affiliation_string":"Department of Infection Biology and Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK","institution_ids":["https://openalex.org/I146655781"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066429649","display_name":"Andrew Owen","orcid":"https://orcid.org/0000-0002-9819-7651","observed_orcids":["https://orcid.org/0000-0002-9819-7651"]},"institutions":[{"id":"https://openalex.org/I146655781","display_name":"University of Liverpool","ror":"https://ror.org/04xs57h96","country_code":"GB","type":"education","lineage":["https://openalex.org/I146655781"]},{"id":"https://openalex.org/I4405260362","display_name":"Centre of Excellence for Long-acting Therapeutics","ror":"https://ror.org/03mmsx307","country_code":"GB","type":"facility","lineage":["https://openalex.org/I146655781","https://openalex.org/I4405260362"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew Owen","raw_affiliation_strings":["Centre of Excellence in Long acting Therapeutics (CELT), University of Liverpool, Liverpool, L69 3BX, UK","Department of Pharmacology and Therapeutics, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK"],"raw_orcid":"https://orcid.org/0000-0002-9819-7651","affiliations":[{"raw_affiliation_string":"Centre of Excellence in Long acting Therapeutics (CELT), University of Liverpool, Liverpool, L69 3BX, UK","institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4405260362"]},{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, Materials Innovation Factory, University of Liverpool, Liverpool, L7 3NY, UK","institution_ids":["https://openalex.org/I146655781"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5066429649"],"corresponding_institution_ids":["https://openalex.org/I146655781","https://openalex.org/I4405260362"],"apc_list":{"value":2464,"currency":"GBP","value_usd":3696},"apc_paid":null,"fwci":0.369,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.40018375,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"76","issue":"9","first_page":"2230","last_page":"2233"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9491999745368958,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11754","display_name":"SARS-CoV-2 detection and testing","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antiviral-resistance","display_name":"antiviral resistance","score":0.8840000033378601},{"id":"https://openalex.org/keywords/covid-19-treatment","display_name":"COVID-19 treatment","score":0.8629999756813049},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.5630000233650208},{"id":"https://openalex.org/keywords/antiviral-drug-discovery","display_name":"antiviral drug discovery","score":0.6240000128746033},{"id":"https://openalex.org/keywords/influenza-virus","display_name":"influenza virus","score":0.3630000054836273},{"id":"https://openalex.org/keywords/hiv-drug-resistance","display_name":"HIV drug resistance","score":0.7889999747276306}],"concepts":[{"id":"https://openalex.org/C2777200299","wikidata":"https://www.wikidata.org/wiki/Q52943","display_name":"Conversation","level":2,"score":0.6349061727523804},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5598886609077454},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5484049916267395},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.5240854620933533},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.5031148791313171},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.4414989948272705},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.40729862451553345},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2332916259765625},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.20886361598968506},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.16395655274391174},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.14723315834999084},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.13427424430847168},{"id":"https://openalex.org/C46312422","wikidata":"https://www.wikidata.org/wiki/Q11024","display_name":"Communication","level":1,"score":0.11490485072135925},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.10997399687767029},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.08156996965408325}],"mesh":[{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093485","descriptor_name":"COVID-19 Drug Treatment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018352","descriptor_name":"Coronavirus Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D024882","descriptor_name":"Drug Resistance, Viral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jac/dkab189","doi":"https://doi.org/10.1093/jac/dkab189","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dkab189","pdf_url":"https://academic.oup.com/jac/article-pdf/76/9/2230/39711670/dkab189.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:34142123","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34142123","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8361339","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8361339/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"J Antimicrob Chemother","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/jac/dkab189","doi":"https://doi.org/10.1093/jac/dkab189","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jac/dkab189","pdf_url":"https://academic.oup.com/jac/article-pdf/76/9/2230/39711670/dkab189.pdf","source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1590801500","display_name":"AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment","funder_award_id":"221590","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G2341205921","display_name":null,"funder_award_id":"EP/R024804/1; EP/S012265/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G2400908033","display_name":null,"funder_award_id":"BB/N022505/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G3285904808","display_name":"Long acting NRTI therapies for HIV","funder_award_id":"R01AI134091","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G3745968079","display_name":null,"funder_award_id":"332228521","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G4712031677","display_name":"China Partnering Award: Exchange of vaccine technology for delivery of oral vaccines to mucosal surfaces","funder_award_id":"BB/N022505/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G4825423275","display_name":"The role of LC3-associated phagocytosis during virus infection","funder_award_id":"BB/R00904X/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G4960261155","display_name":"BPIFA1: from anti-viral peptide to immunomodulator","funder_award_id":"BB/R018863/1","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G5036412451","display_name":"New Branched Polymers Excipients and Emulsions for Enhanced Drug Delivery","funder_award_id":"EP/R024804/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G6005504565","display_name":"An Injectable Implant Providing Long-Acting Drug Delivery for the Treatment of Chronic disease","funder_award_id":"EP/S012265/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G6386172277","display_name":"Regulatory Science Framework for Nano(bio)material-based Medical Products and Devices","funder_award_id":"761104","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G697565132","display_name":null,"funder_award_id":"332228521","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G7078208406","display_name":"Targeting the RNA helicase, UAP56: understanding KSHV RNA processing mechanisms to novel antiviral approaches","funder_award_id":"MR/R010145/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G7620128503","display_name":null,"funder_award_id":"EP/R024804/1","funder_id":"https://openalex.org/F4320314731","funder_display_name":"UK Research and Innovation"},{"id":"https://openalex.org/G7648148677","display_name":"AGILE: Seamless Phase I/IIa Platform for the Rapid Evaluation of Candidates for COVID-19 treatment","funder_award_id":"MR/V028391/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G8817154565","display_name":null,"funder_award_id":"75F40120C00085","funder_id":"https://openalex.org/F4320311904","funder_display_name":"Wellcome Trust"},{"id":"https://openalex.org/G9000903012","display_name":"The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)","funder_award_id":"R24AI118397","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320311904","display_name":"Wellcome Trust","ror":"https://ror.org/029chgv08"},{"id":"https://openalex.org/F4320314731","display_name":"UK Research and Innovation","ror":"https://ror.org/001aqnf71"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"},{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"},{"id":"https://openalex.org/F4320335087","display_name":"Innovate UK","ror":"https://ror.org/05ar5fy68"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F8128777614","display_name":"Unitaid","ror":"https://ror.org/05t99je22"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3171409443.pdf","grobid_xml":"https://content.openalex.org/works/W3171409443.grobid-xml"},"referenced_works_count":43,"referenced_works":["https://openalex.org/W45542692","https://openalex.org/W1693165432","https://openalex.org/W2008137278","https://openalex.org/W2064436486","https://openalex.org/W2138198678","https://openalex.org/W2142239450","https://openalex.org/W2552113437","https://openalex.org/W2606218024","https://openalex.org/W2785408029","https://openalex.org/W2793022939","https://openalex.org/W3006274289","https://openalex.org/W3013944367","https://openalex.org/W3032915827","https://openalex.org/W3036391214","https://openalex.org/W3042270788","https://openalex.org/W3043391491","https://openalex.org/W3045870925","https://openalex.org/W3049233984","https://openalex.org/W3065795114","https://openalex.org/W3080156899","https://openalex.org/W3080704959","https://openalex.org/W3087207483","https://openalex.org/W3092684668","https://openalex.org/W3093588691","https://openalex.org/W3099062642","https://openalex.org/W3102258632","https://openalex.org/W3102798166","https://openalex.org/W3103744434","https://openalex.org/W3105567477","https://openalex.org/W3110736654","https://openalex.org/W3112541288","https://openalex.org/W3113473864","https://openalex.org/W3125712166","https://openalex.org/W3135383916","https://openalex.org/W3138734145","https://openalex.org/W4210305993","https://openalex.org/W4213073926","https://openalex.org/W4244376324","https://openalex.org/W4308148743","https://openalex.org/W6787738718","https://openalex.org/W6792170256","https://openalex.org/W6981056826","https://openalex.org/W7070919894"],"related_works":["https://openalex.org/W4410519966","https://openalex.org/W4394935951","https://openalex.org/W4412751445","https://openalex.org/W4406412104","https://openalex.org/W7126674794","https://openalex.org/W4382052160","https://openalex.org/W4297629919","https://openalex.org/W3120059037","https://openalex.org/W7211999160","https://openalex.org/W4304789114"],"abstract_inverted_index":{"This":[0],"article":[1],"provides":[2],"a":[3,92],"brief":[4],"overview":[5],"of":[6,41,51,88,128],"drug":[7,35,54,62,84,97],"resistance":[8,36,98],"to":[9,27,33,38,57,125],"antiviral":[10],"therapy":[11],"as":[12,14,75],"well":[13],"known":[15],"and":[16,78,109,115,133],"emergent":[17],"variability":[18],"in":[19,79,82,99],"key":[20,83],"SARS-CoV-2":[21,100],"viral":[22],"sequences.":[23],"The":[24,94],"purpose":[25],"is":[26],"stimulate":[28],"deliberation":[29],"about":[30],"the":[31],"need":[32],"consider":[34],"prior":[37,124],"widespread":[39,126],"roll-out":[40,127],"antivirals":[42],"for":[43,60,70,96,112,130],"SARS-CoV-2.":[44],"Many":[45],"existing":[46],"candidate":[47],"agents":[48],"have":[49],"mechanisms":[50],"action":[52],"involving":[53],"targets":[55,85],"likely":[56],"be":[58],"critical":[59],"future":[61,122],"development.":[63],"Resistance":[64],"emerged":[65],"quickly":[66],"with":[67],"monotherapies":[68,129],"deployed":[69],"other":[71],"pulmonary":[72],"viruses":[73],"such":[74],"influenza":[76],"virus,":[77],"HIV":[80],"mutations":[81],"compromised":[86],"efficacy":[87],"multiple":[89],"drugs":[90],"within":[91],"class.":[93],"potential":[95],"has":[101],"not":[102],"yet":[103],"been":[104],"rigorously":[105],"debated":[106],"or":[107],"assessed,":[108],"we":[110],"call":[111],"more":[113],"academic":[114],"industry":[116],"research":[117],"on":[118],"this":[119],"potentially":[120],"important":[121],"threat":[123],"COVID-19":[131],"treatment":[132],"prevention.":[134]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2021-06-22T00:00:00"}